1.Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the
use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;24:5313-27.
2.日本肝臓学会. 肝癌診療ガイドライン 2013 年版.
3.Buys SS, Partridge E, Black A, et al. Effect of screening on ovarian cancer mortality:
the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized
Controlled Trial. JAMA 2011;305:2295-303.
4.Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate cancer mortality:
results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at
13 years of follow-up. Lancet 2014;384:2027-35.
5.Andriole GL, Crawford ED, Grubb RL, 3rd, et al. Mortality results from a randomized
prostate-cancer screening trial. N Engl J Med 2009;360:1310-9.